X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with PLETHICO PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs PLETHICO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE PLETHICO PHARMA TTK HEALTHCARE/
PLETHICO PHARMA
 
P/E (TTM) x 36.7 -1.1 - View Chart
P/BV x 6.8 0.0 40,316.0% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 TTK HEALTHCARE   PLETHICO PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
PLETHICO PHARMA
Mar-14
TTK HEALTHCARE/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs663395 168.0%   
Low Rs39931 1,274.8%   
Sales per share (Unadj.) Rs535.6604.4 88.6%  
Earnings per share (Unadj.) Rs15.932.5 49.1%  
Cash flow per share (Unadj.) Rs20.051.3 39.0%  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs137.6473.6 29.1%  
Shares outstanding (eoy) m7.7734.08 22.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.00.4 281.3%   
Avg P/E ratio x33.36.6 507.7%  
P/CF ratio (eoy) x26.54.2 638.9%  
Price / Book Value ratio x3.90.5 857.8%  
Dividend payout %25.10-   
Avg Mkt Cap Rs m4,1277,262 56.8%   
No. of employees `0001.7NA-   
Total wages/salary Rs m6071,596 38.0%   
Avg. sales/employee Rs Th2,436.7NM-  
Avg. wages/employee Rs Th355.2NM-  
Avg. net profit/employee Rs Th72.5NM-  
INCOME DATA
Net Sales Rs m4,16220,598 20.2%  
Other income Rs m61386 15.8%   
Total revenues Rs m4,22320,984 20.1%   
Gross profit Rs m1972,818 7.0%  
Depreciation Rs m32642 4.9%   
Interest Rs m301,593 1.9%   
Profit before tax Rs m197969 20.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m73-138 -52.6%   
Profit after tax Rs m1241,107 11.2%  
Gross profit margin %4.713.7 34.6%  
Effective tax rate %37.0-14.3 -259.0%   
Net profit margin %3.05.4 55.4%  
BALANCE SHEET DATA
Current assets Rs m1,62918,877 8.6%   
Current liabilities Rs m1,05811,896 8.9%   
Net working cap to sales %13.733.9 40.5%  
Current ratio x1.51.6 97.0%  
Inventory Days Days3036 82.9%  
Debtors Days Days34198 17.0%  
Net fixed assets Rs m5569,861 5.6%   
Share capital Rs m78341 22.8%   
"Free" reserves Rs m87812,331 7.1%   
Net worth Rs m1,06916,139 6.6%   
Long term debt Rs m1594,706 3.4%   
Total assets Rs m2,39933,146 7.2%  
Interest coverage x7.61.6 471.3%   
Debt to equity ratio x0.10.3 50.9%  
Sales to assets ratio x1.70.6 279.1%   
Return on assets %6.48.1 78.7%  
Return on equity %11.66.9 168.9%  
Return on capital %18.512.3 150.1%  
Exports to sales %0.821.4 3.7%   
Imports to sales %1.415.2 9.2%   
Exports (fob) Rs m334,402 0.7%   
Imports (cif) Rs m583,136 1.9%   
Fx inflow Rs m334,402 0.7%   
Fx outflow Rs m633,184 2.0%   
Net fx Rs m-301,219 -2.5%   
CASH FLOW
From Operations Rs m1272,437 5.2%  
From Investments Rs m-146-6,265 2.3%  
From Financial Activity Rs m222,490 0.9%  
Net Cashflow Rs m3-1,337 -0.2%  

Share Holding

Indian Promoters % 65.4 82.7 79.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 4.3 86.0%  
FIIs % 5.2 5.5 94.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 7.5 344.0%  
Shareholders   12,723 10,665 119.3%  
Pledged promoter(s) holding % 0.0 85.7 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  CADILA HEALTHCARE  NOVARTIS  DR. DATSONS LABS  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Up; ONGC & Tata Steel Top Gainers(Closing)

Indian share markets ended the day on a strong note. At the closing bell, the BSE Sensex finished higher by 262 points. While, the NSE Nifty finished up by 91 points.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


May 25, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS